Hosted By
In this special Cambridge Tech Week podcast episode we chat to Umaima Ahmad, CEO and co-founder of 52North, a multi-award winning med-tech company focused on reinventing the healthcare journey, starting by transforming cancer care with Neutrocheck®. She shares lessons learned from the early days of Neutrocheck to the company recently being the first ever venture investment of Macmillan Cancer Support.
Hear how Umaima moved from a successful career as a finance lawyer into the world of entrepreneurship and healthcare, via her role in business development at AstraZeneca. She tells us about how the idea came about, the importance of good hires and provides some tips on securing early investors.
Jason Mellad is a passionate entrepreneur, scientist, and CEO. He's also co-founder of Start Codon - a Cambridge based accelerator which aims to identify,...
Lluna Gallego Segrelles is the CEO and co-founder of Vector Bioscience, a trailblazing biotech that's redefining drug delivery through its innovative AI enabled nano...
Today on the podcast, we’re joined by Dr Jon Moore — a biochemist, entrepreneur, and seasoned biotech leader whose career spans both cutting-edge academic...
